首页> 外文OA文献 >231: Clinical Outcome after Multicenter, Open-Label Phase II Trial on Post-Surgery Chemoradiation in Combination with Cetuximab in Squamous Cell Carcinoma of the Head and Neck with High-Risk of Locoregional Recurrence

【2h】

231: Clinical Outcome after Multicenter, Open-Label Phase II Trial on Post-Surgery Chemoradiation in Combination with Cetuximab in Squamous Cell Carcinoma of the Head and Neck with High-Risk of Locoregional Recurrence

机译：231：在头颈部鳞状细胞癌伴局部高发区复发的头颈部鳞状细胞癌的手术后化学放疗联合西妥昔单抗的多中心，开放标签II期临床试验后的临床结果

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
Boelke Edwin; Matuschek Christiane; Schipper Joerg; Budach Volker; Belka Claus; Debus Juergen; Wendt Thomas; Stuschke Martin; Wenz Frederick; Henke Michael; Budach Wilfried;
展开▼
作者单位

展开▼
年度 2016
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Association of Human Papillomavirus and p16 Status With Outcomes in the IMCL-9815 Phase III Registration Trial for Patients With Locoregionally Advanced Oropharyngeal Squamous Cell Carcinoma of the Head and Neck Treated With Radiotherapy With or Without Cetuximab [J] . Rosenthal David I., Harari Paul M., Giralt Jordi, Journal of Clinical Oncology . 2016,第12期

机译：IMCL-9815 III期注册试验中人乳头瘤病毒和p16状态与结局的关系，接受或不接受西妥昔单抗的放疗治疗头颈部局部区域性咽咽鳞状细胞癌
2. Phase 2, open-label, 1:1 randomized controlled trial exploring the efficacy of EMD 1201081 in combination with cetuximab in second-line cetuximab-na < ve patients with recurrent or metastatic squamous cell carcinoma of the head and neck (R/M SCCHN) [J] . Ruzsa A., Sen M., Evans M., Investigational new drugs. . 2014,第6期

机译：2期，开放标签，1：1随机对照试验，探讨EMD 1201081联合西妥昔单抗治疗第二线西妥昔单抗-初次复发或转移性头颈部鳞状细胞癌（R / M SCCHN）的患者的疗效）
3. A Multicenter Phase II Trial of Docetaxel, Cisplatin, and Cetuximab (TPEx) Followed by Cetuximab and Concurrent Radiotherapy for Patients With Local Advanced Squamous Cell Carcinoma of the Head and Neck (CSPOR HN01: ECRIPS Study) [J] . Sadamoto Zenda, Yosuke Ota, Naomi Kiyota, Frontiers in Oncology . 2019,第2016期

机译：多西他赛，顺铂和西妥昔单抗（TPEx）继之以西妥昔单抗和并行放疗的多中心II期临床试验，用于头颈部局部晚期鳞状细胞癌患者（CSPOR HN01：ECRIPS研究）
4. Interstitial photodynamic therapy in combination with Cetuximab for recurrent head and neck squamous cell carcinoma [C] . Nestor Rigual, Ambujakshan Dildeep, Gal Shafirstein Conference on photonic therapeutics and diagnostics IX . 2013

机译：间质性光动力疗法联合西妥昔单抗治疗复发性头颈部鳞状细胞癌
5. GGTI-298 in combination with EGFR inhibitors: Evaluating a novel therapy in head and neck squamous cell carcinomas. [D] . Zahr, Stephanie. 2013

机译：GGTI-298与EGFR抑制剂联合使用：评价头颈部鳞状细胞癌的新疗法。
6. Association of Human Papillomavirus and p16 Status With Outcomes in the IMCL-9815 Phase III Registration Trial for Patients With Locoregionally Advanced Oropharyngeal Squamous Cell Carcinoma of the Head and Neck Treated With Radiotherapy With or Without Cetuximab [O] . David I. Rosenthal, Paul M. Harari, Jordi Giralt, -1

机译：IMCL-9815 III期注册试验中人乳头瘤病毒和p16状态与结局的关系接受或不接受西妥昔单抗的放疗治疗头颈部局部区域性咽咽鳞状细胞癌
7. Association of Human Papillomavirus and p16 Status With Outcomes in the IMCL-9815 Phase III Registration Trial for Patients With Locoregionally Advanced Oropharyngeal Squamous Cell Carcinoma of the Head and Neck Treated With Radiotherapy With or Without Cetuximab [O] . David I. Rosenthal, Paul M. Harari, Jordi Giralt, 2016

机译：人类乳头瘤病毒和P16状态在IMCL-9815期III期注册试验中的结果，用于患有有或不含西妥昔单抗的放射治疗的头部和颈部的脑部和颈部的患者

231: Clinical Outcome after Multicenter, Open-Label Phase II Trial on Post-Surgery Chemoradiation in Combination with Cetuximab in Squamous Cell Carcinoma of the Head and Neck with High-Risk of Locoregional Recurrence

著录项

相似文献

相关主题

期刊订阅